KI signs agreement with biotech organization in India
Karolinska Institutet has signed an agreement to support stipends for post-doctoral students from the Regional Centre for Biotechnology (RCB) in India. The agreement is intended to promote collaborations in several projects in translation medicine and innovation at the Center for Molecular Medicine (CMM), Karolinska Institutet.
The post-doc program is for one year with the possibility of extension for another year after an evaluation process.
- This initiative will increase the collaboration between CMM and research groups in India and serve as a platform for newer ways to innovate and commercialize scientific ideas to products, says Sanjeevi Carani, researcher at CMM, Karolinska Institutet.
The program is planned to start in the fall of 2016, after the selection process and the first Indian researchers scheduled to arrive in CMM before the end of the year.